©The Author(s) 2026.
World J Orthop. Feb 18, 2026; 17(2): 113667
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.113667
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.113667
Table 2 Patient demographics (n = 81), n (%)
| Characteristic | Value |
| Age (mean ± SD, range) | 68.3 ± 9.1, 52-88 |
| Gender | |
| Male | 46 (56.79) |
| Female | 35 (43.21) |
| BMI (mean ± SD, range) | 35.3 ± 8.5, 19.2-61.9 |
| 10-year survival (mean ± SD, range, %) | 65.4 ± 17.0, 0-95.9 |
| Comorbid conditions | |
| DM | 21 (25.93) |
| HLD | 34 (41.98) |
| HTN | 64 (79.01) |
| Obesity (BMI > 35) | 38 (46.91) |
| AFIB | 9 (11.11) |
| CKD | 12 (14.81) |
| Smoking | 3 (3.70) |
| Anxiety/depression | 40 (49.38) |
| Sleep apnea | 25 (30.86) |
- Citation: Sweeney BM, Sadhwani S, Edwards T, Kelly M. Value of “true” leukocytosis formula in determining total knee arthroplasty prosthetic joint infection in the community hospital setting. World J Orthop 2026; 17(2): 113667
- URL: https://www.wjgnet.com/2218-5836/full/v17/i2/113667.htm
- DOI: https://dx.doi.org/10.5312/wjo.v17.i2.113667